Nasopharyngeal Neoplasms

Download PDF

Recent Publications on Nasopharyngeal Neoplasms:
MR imaging of nonmalignant polyps and masses of the nasopharynx and sphenoid sinus after radiotherapy for nasopharyngeal carcinoma. BACKGROUND AND PURPOSE: The development of a new polyp or mass in the...	11th July, 2008	Department of Diagnostic Radiology and Organ Imaging, Faculty of Medicine,	AJNR Am J Neuroradiol. 2008 Jun;29(6):1209-14. Epub 2008 May 8. DOI Direct Link
Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells. 5-Fluorouracil (5-FU) is an important chemotherapeutic agent for...	4th July, 2008	Department of Pharmacology, School of Pharmaceutical Science, Central	Biochem Biophys Res Commun. 2008 Jul 4;371(3):531-5. Epub 2008 Apr 29. DOI Direct Link
Postirradiated neuroendocrine carcinoma of the sinonasal tract. OBJECTIVES/HYPOTHESIS: Neuroendocrine carcinoma (NEC) of the sinonasal...	25th June, 2008	Institute of Biomedical Engineering, College of Medicine, National Taiwan	Laryngoscope. 2008 May;118(5):804-9. DOI Direct Link
Nasopharyngeal carcinoma with orbital involvement. PURPOSE: To describe the clinical presentation of patients with...	20th June, 2008	Singapore National	Ophthal Plast Reconstr Surg. 2008 May-Jun;24(3):185-9. DOI Direct Link
Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions. Systemic therapy is an integral part of the management of non-keratinizing...	18th June, 2008	Department of Clinical Oncology at the Sir Y. K. Pao Center for Cancer,	Cancer Sci. 2008 Jul;99(7):1311-8. Epub 2008 May 21. DOI Direct Link
→View more research publications.

Nasopharyngeal Neoplasms Clinical Trials:
Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer	Nasopharyngeal Neoplasms
Vaccine Therapy or Observation in Treating Patients With Nasopharyngeal Cancer at High Risk for Recurrence	Head and Neck Cancer
Pazopanib in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer	Head and Neck Cancer
T Lymphocytes and Anti-CD45 Monoclonal Antibody in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer	Head and Neck Cancer
Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx	Head and Neck Cancer
→View more trials.

Nasopharyngeal Neoplasms Patents:
US Patent No.	Title
7232667	Keratinocyte growth factor-2 polynucleotides
6693077	Keratinocyte growth factor-2
6385611	System and method for database retrieval, indexing and statistical analysis

BioPortfolio Ltd. offers e-mail and postal lists for Nasopharyngeal Neoplasms scientists - we have details of around 893 individuals working on Nasopharyngeal Neoplasms .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.